How Generic Pharma Manufacturers Can Rebuild Margins Inside The Four Walls
By Nero Haralalka, director – U.S. Consulting, TBM Consulting Group Generic drug manufacturers face relentless pressure from price erosion, customer concentration, and supply instability. In that environment, the most reliable
Pharma 4.0 Market Size, Share, Growth Analysis
Overview New York, NY – Feb 27, 2026 – The Global Pharma 4.0 Market size is expected to be worth around US$ 67.7 Billion by 2033, from US$ 11.9 Billion in 2023, growing at a CAGR of 18.9% during
Pharma Manufacturing Professionals Are Staying Put Despite Growing Uncertainty
The PharmTech annual survey of employment trends, conducted during the fourth quarter (Q4) of 2025, reveals a workforce navigating a complex period of high personal engagement and systemic instability. While
IGMPI Advances Pharma & Healthcare with Next-Gen Digital GMP Training
• 1 hour ago • 3 Mins Read By Prof. Dr. Syed S. Abbas, Director, Institute of Good Manufacturing Practices India (IGMPI) As the healthcare and pharmaceutical sectors embrace digital
AUTOMA+ 2025 spotlights AI and digital plant modeling in pharma
AUTOMA+ 2025 brought together pharma and tech leaders in Vösendorf, Austria on November 24–25 to explore the latest developments in digital R&D, lab automation and manufacturing. The Pharmaceutical Automation and
Attracting, Retaining Talent: Key Challenges for Pharma
Q: What are the biggest human capital challenges the pharmaceutical sector faces? A: One of the most significant challenges is attracting and retaining specialized talent in a highly competitive and